Literature DB >> 20031717

Extended follow-up by serial angioscopic observation for bare-metal stents in native coronary arteries: from healing response to atherosclerotic transformation of neointima.

Shinya Yokoyama1, Masamichi Takano, Masanori Yamamoto, Shigenobu Inami, Shunta Sakai, Kentaro Okamatsu, Shinichi Okuni, Koji Seimiya, Daisuke Murakami, Takayoshi Ohba, Ryota Uemura, Yoshihiko Seino, Noritake Hata, Kyoichi Mizuno.   

Abstract

BACKGROUND: Although coronary angiograms after bare-metal stent (BMS) implantation show late luminal narrowing beyond 4 years, the detailed changes inside the BMS have not yet been fully elucidated. METHODS AND
RESULTS: Serial angiographic and angioscopic examinations were performed immediately (baseline), 6 to 12 months (first follow-up), and >or=4 years (second follow-up) after stenting without target lesion revascularization in 26 segments of 26 patients who received BMS deployment for their native coronary arteries. Angioscopic observation showed atherosclerotic yellow plaque crushed out by stent struts in 22 patients (85%) and mural thrombus in 21 patients (81%) at baseline. At first follow-up, white neointimal hyperplasia was almost completely buried inside the struts, and both yellow plaque and thrombus had decreased in comparison with baseline (12% and 4%, respectively; P<0.001). The frequencies of yellow plaque and thrombus increased from the first to second follow-ups (58% and 31%, respectively; P<0.05). All of the yellow plaques in the second follow-up were located not exterior to the struts but protruding from the vessel wall into the lumen. Late luminal narrowing, defined as an increasing of percent diameter stenosis between the first and second follow-ups, was greater in segments with yellow plaque than in those without yellow plaque (18.4+/-17.3% versus 3.6+/-4.2%, respectively; P=0.011).
CONCLUSIONS: This angiographic and angioscopic study suggests that white neointima of the BMS may often change into yellow plaque over an extended period of time, and atherosclerotic progression inside the BMS may contribute to late luminal narrowing.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20031717     DOI: 10.1161/CIRCINTERVENTIONS.109.854679

Source DB:  PubMed          Journal:  Circ Cardiovasc Interv        ISSN: 1941-7640            Impact factor:   6.546


  10 in total

1.  Neoatherosclerosis assessed with optical coherence tomography in restenotic bare metal and first- and second-generation drug-eluting stents.

Authors:  Lei Song; Gary S Mintz; Dong Yin; Myong Hwa Yamamoto; Chee Yang Chin; Mitsuaki Matsumura; Khady Fall; Ajay J Kirtane; Manish A Parikh; Jeffrey W Moses; Ziad A Ali; Richard A Shlofmitz; Akiko Maehara
Journal:  Int J Cardiovasc Imaging       Date:  2017-03-09       Impact factor: 2.357

2.  Long-term changes in neointimal hyperplasia following implantation of bare metal stents assessed by integrated backscatter intravascular ultrasound.

Authors:  Shinichiro Tanaka; Toshiyuki Noda; Makoto Iwama; Shintaro Tanihata; Masanori Kawasaki; Kazuhiko Nishigaki; Taro Minagawa; Sachiro Watanabe; Shinya Minatoguchi
Journal:  Heart Vessels       Date:  2012-07-25       Impact factor: 2.037

3.  A higher colour grade yellow plaque was detected at one year after implantation of an everolimus-eluting stent than after a zotarolimus-eluting stent.

Authors:  Koshi Matsuo; Yasunori Ueda; Mayu Nishio; Akio Hirata; Mitsutoshi Asai; Takayoshi Nemoto; Ayaka Murakami; Kazunori Kashiwase; Kazuhisa Kodama
Journal:  Heart Asia       Date:  2013-09-07

4.  Vascular response to paclitaxel-eluting nitinol self-expanding stent in superficial femoral artery lesions: post-implantation angioscopic findings from the SHIMEJI trial (Suppression of vascular wall Healing after IMplantation of drug Eluting peripheral stent in Japanese patients with the Infra inguinal lesion: serial angioscopic observation).

Authors:  Yoshiro Tsukiyama; Toshiro Shinke; Takayuki Ishihara; Hiromasa Otake; Daisuke Terashita; Amane Kozuki; Masashi Fukunaga; Kan Zen; Tetsuo Horimatsu; Kenichi Fujii; Junya Shite; Masaaki Uematsu; Mitsuyoshi Takahara; Osamu Iida; Shinsuke Nanto; Ken-Ichi Hirata
Journal:  Int J Cardiovasc Imaging       Date:  2019-06-14       Impact factor: 2.357

Review 5.  Intravascular optical imaging technology for investigating the coronary artery.

Authors:  Melissa J Suter; Seemantini K Nadkarni; Giora Weisz; Atsushi Tanaka; Farouc A Jaffer; Brett E Bouma; Guillermo J Tearney
Journal:  JACC Cardiovasc Imaging       Date:  2011-09

Review 6.  Neoatherosclerosis: Coronary stents seal atherosclerotic lesions but result in making a new problem of atherosclerosis.

Authors:  Hidenori Komiyama; Masamichi Takano; Noritake Hata; Yoshihiko Seino; Wataru Shimizu; Kyoichi Mizuno
Journal:  World J Cardiol       Date:  2015-11-26

7.  Identification of vulnerable plaque in a stented coronary segment 17 years after implantation using optical coherence tomography.

Authors:  Jeong Hoon Yang; Kyeongmin Byeon; Hyeon-Cheol Gwon; Jeong Euy Park; Young Bin Song
Journal:  Yonsei Med J       Date:  2012-03       Impact factor: 2.759

Review 8.  OCT demonstrating neoatherosclerosis as part of the continuous process of coronary artery disease.

Authors:  B-C Zhang; A Karanasos; E Regar
Journal:  Herz       Date:  2015-09       Impact factor: 1.443

9.  Propylthiouracil-coated biodegradable polymer inhibited neointimal formation and enhanced re-endothelialization after vascular injury.

Authors:  Shang-Hung Chang; Cheng-Hung Lee; Yung-Hsin Yeh; Shih-Jung Liu; Chao-Jan Wang; Ming-Yi Hsu; Wei-Jan Chen
Journal:  Int J Nanomedicine       Date:  2018-03-21

10.  The comparison of early healing 1-month after PCI among CoCr-everolimus-eluting stent (EES), biodegradable polymer (BP)-EES and BP-sirolimus-eluting stent: Insights from OFDI and coronary angioscopy.

Authors:  Takao Sato; Yuji Taya; Naomasa Suzuki; Sho Yuasa; Shohei Kishi; Tomoyasu Koshikawa; Koichi Fuse; Satoshi Fujita; Yoshio Ikeda; Hitoshi Kitazawa; Minoru Takahashi; Masaaki Okabe; Yoshifusa Aizawa
Journal:  Int J Cardiol Heart Vasc       Date:  2018-08-17
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.